Raymond C. Mellinger, M.D.; Robert J. Thompson, M.D.
This content is PDF only. Please click on the PDF icon to access.
Clomiphene citrate (MRL-41), a derivative of the synthetic estrogen TACE, is a new drug with unique properties of therapeutic potential for such diversified conditions as amenorrhea, anovulation, postjartum lactation, Chiari-Frommel syndrome, cystic mastitis, and oligospermia.
The following observations in patients receiving clomiphene illustrate its effects and imply a primary mechanism of action: (1) sperm counts and urinary 17-ketosteroids increased significantly in 9 of 12 oligospermic men, with markedly increased gonadotropins in all subjects; (2) ovulation occurred in 4 or 5 anovulatory women, with inhibited endometrial growth in one case; (3) vaginal cornification was markedly reduced and gonadotropins increased (1 of
Mellinger RC, Thompson RJ. The Effects of Clomiphene Citrate in Patients with Pituitary-gonadal Disorders.. Ann Intern Med. ;60:717. doi: 10.7326/0003-4819-60-4-717_1
Download citation file:
Published: Ann Intern Med. 1964;60(4):717.
Endocrine and Metabolism, Neurology, Pituitary Disorders.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use